Shamoun Ahmad | Episode 27

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/ec/e4/2a/ece42ab7-6c03-75ae-7897-add688de7323/mza_61325501970969523.jpg/600x600bb.jpg

The Only Way Is Ethics

DPM Digital Health

36 episodes

1 week ago

Welcome to The Only Way Is Ethics, the podcast from Dean Mawson, Clinical Director / Founder of DPM Digital Health. With this podcast, we aim to get out there and chat to people within the sector, and invite guests in to talk about clinical risk management but also many other topics within the sector. After many years working in digital health, Dean has forged a great many friendships with likeminded individuals, who we are now calling on to have open and honest chats about the industry.

Business

RSS

All content for The Only Way Is Ethics is the property of DPM Digital Health and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Business

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/41574871/41574871-1755851303374-c54af72436915.jpg

Shamoun Ahmad | Episode 27

The Only Way Is Ethics

1 hour 22 seconds

2 months ago

Shamoun Ahmad | Episode 27

In this episode, Dean Mawson sits down with health tech innovator Shamoun Ahmad, founder of Medeskin AI, to explore the intersection of artificial intelligence, dermatology, and NHS transformation. With a vision rooted in accessible, early-stage diagnosis, Shamoun shares the journey behind Medeskin AI and its role in reshaping skin health services.

We discuss how Medeskin AI aligns with the NHS 10-Year Plan, supporting ambitions to become the most AI-enabled healthcare system in the world. From AI-powered skin cancer pathways to potential inclusion in the future NHS “HealthStore” procurement framework, Shamoun outlines how Medeskin aims to scale nationally and equitably.

The episode delves into the ethics and utility of Ambient Voice Transcription (AVT) and Generative AI in clinical settings, and how technologies like large language models (LLMs) can enhance evidence synthesis, health technology assessment, and even clinical trial design. Shamoun reflects on Medeskin’s use of these tools to validate diagnostics while reducing clinician burden.

We explore Medeskin’s unique workflow—from patient photo uploads to instant GP notifications and AI-driven triage—and how this model supports underserved communities, improves dermatology access, and aligns with key NHS use cases, such as GP triage, dermatology referrals, and two-week-wait target compliance.

Trust and transparency take centre stage as Shamoun explains how Medeskin navigates NHS Information Governance (IG) and GDPR, ensuring data control, explainability, and fairness in every AI-driven decision. The company’s adoption of FUTURE-AI principles (Fairness, Transparency, Robustness, etc.) reflects a strong ethical commitment.

This episode is essential listening for anyone navigating AI in healthcare, particularly where innovation meets clinical need, ethical design, and system-wide adoption.

This podcast is for informational purposes only and should not be considered legal health advice.

We are not responsible for any losses, damages, or liabilities that may arise from the use of this podcast.

This podcast is not intended to replace professional medical advice.

The views expressed in this podcast may not be those of the host or the management.